How to Get a Colonoscopy Fully Covered in 2026: The Preventive vs Diagnostic Trap, Polyp Removal Loophole, and Anesthesia and Pathology Gotchas

Your gastroenterologist told you the screening colonoscopy would be free. Your insurer's summary of benefits says the same thing. You did the prep, you slept through the scope, you woke up feeling fine — and three weeks later you got a bill for $1,847. Or $2,300. Or, in one common variant of the surprise, a modest $215 charge from an anesthesia group you never met and a separate $340 pathology invoice that arrived a month after the facility bill.

None of that is what the Affordable Care Act promised. Under Section 2713 of the ACA, non-grandfathered health plans must cover United States Preventive Services Task Force (USPSTF) A- and B-rated preventive services with no cost sharing — no deductible, no coinsurance, no copay. Screening colonoscopy for average-risk adults 45–75 is a Grade A recommendation. So why do so many screening colonoscopies still generate a bill?

Because a colonoscopy is one of the few preventive services in the ACA catalog that involves multiple providers (endoscopist, facility, anesthesia, pathology), multiple codes, and a well-worn history of miscoding. Small billing choices upstream — a diagnosis code on the referral, a modifier that never made it onto the anesthesia claim, a polyp that got billed as therapy instead of as part of the screen — turn a $0 procedure into a four-figure bill. Here's the 2026 playbook for keeping your screening fully covered: what the federal rules actually say, which codes and modifiers your providers need to use, the two loopholes that used to trap patients (and are now closed if you know to check), and the exact appeal that reverses a surprise bill.

The core rule is ACA Section 2713, which requires non-grandfathered plans (which is the overwhelming majority of employer and marketplace plans in 2026) to cover USPSTF A- and B-rated preventive services in-network with no cost sharing to the patient. For colorectal cancer, that means:

• USPSTF Grade A: Screening for colorectal cancer in adults aged 50 to 75.
• USPSTF Grade B: Screening for colorectal cancer in adults aged 45 to 49.
• USPSTF Grade C: Screening in adults 76 to 85 — a personalized decision. Plans are not required to cover these at $0, though many do.

The rule covers all USPSTF-recommended modalities: high-sensitivity FIT annually, FIT-DNA (Cologuard) every 1–3 years, CT colonography every 5 years, flexible sigmoidoscopy every 5 years (or every 10 with annual FIT), and colonoscopy every 10 years. What matters for cost sharing is that when the screening is done — whichever modality — the plan cannot pass any cost on to the patient in-network.

Two federal FAQ guidance documents did most of the practical work in closing the historical loopholes:

• ACA FAQ Part 51 (January 10, 2022). This is the one that matters most for colonoscopy. It clarified that (a) polyp removal during a screening colonoscopy is an integral part of the screening and must remain fully covered with no cost sharing, and (b) a follow-up colonoscopy after a positive non-invasive stool-based screening test (FIT, gFOBT, FIT-DNA/Cologuard) or a positive CT colonography is part of the preventive screening continuum and must also be covered with no cost sharing.
• Medicare parallel: Traditional Medicare adopted equivalent rules effective January 1, 2023 for follow-up colonoscopies after positive stool tests, and the 2022 rule closing the polyp-removal loophole applies to Medicare via modifier PT rather than modifier 33.

The federal rules are unambiguous. The billing systems, on the other hand, are dozens of independent vendors sharing partial information across four separate providers. The four ways a "free" colonoscopy still generates a bill in 2026:

Notice that in three of the four scenarios, the fix is a billing correction, not a coverage appeal. You do not have to prove the plan owes you the money — the plan already agrees it does under a correctly coded claim. You just have to get the claim resubmitted. Practices resist this because rework is unpaid time, but a persistent written request usually gets it done.

The single most important thing you can do to keep your colonoscopy at $0 is verify the coding plan before the procedure. Once the claim goes out with the wrong codes, you're chasing a correction; before, you're just approving what's already correct.

Call the gastroenterologist's office and ask three things:

• What CPT and HCPCS codes will you bill for a normal screening? The right answer is CPT 45378 with modifier 33 (commercial) or HCPCS G0121 for average-risk Medicare screening / G0105 for high-risk Medicare. Diagnosis code Z12.11 (Encounter for screening for malignant neoplasm of colon).
• What if a polyp is removed? The right answer names the therapeutic CPT (45380, 45384, 45385, 45388 depending on technique) with modifier 33 or PT added. If they hesitate or say "then it's diagnostic," you have found the practice's coding gap before it becomes your bill.
• Who provides anesthesia and pathology, are they in-network with my plan, and what codes do they use? Anesthesia should bill CPT 00812 for screening (not 00811). Pathology should link to the screening encounter, not bill as an unrelated diagnostic study.

Before January 2022, the loophole worked like this. You showed up for a screening colonoscopy. The gastroenterologist found and removed a polyp (which happens in roughly 30–40% of first screenings — that's the point of the procedure). The plan reclassified the visit as therapeutic and billed you the deductible and coinsurance. You did the exact thing the USPSTF recommended, at the exact age recommended, and got charged $1,500 for the privilege.

ACA FAQ Part 51 said no. Specifically: "the required preventive screening includes any medically appropriate polypectomy performed in connection with the preventive screening colonoscopy." So the fact that a polyp was removed does not convert a screening into a diagnostic bill. The provider signals this on the claim with modifier 33 (commercial) or modifier PT (Medicare) on the therapeutic CPT code.

In 2026 this is settled federal policy. But the practical problem is that not every provider consistently appends the modifier, not every plan's claims-processing system correctly recognizes the modifier, and not every anesthesia and pathology billing service knows to follow suit. A HealthCalc reader who chased three bills after her March 2026 screening reported that the endoscopist coded it correctly, but the anesthesia group's coding software auto-selected 00811 (diagnostic) because a polyp was documented — her $340 bill reversed within two weeks after she emailed a copy of ACA FAQ Part 51 to the anesthesia billing office.

The 30-second script when you get the bill: "This was a screening colonoscopy. Under ACA FAQ Part 51 (January 10, 2022), the fact that a polyp was removed does not change the preventive nature of the service. Please resubmit with modifier 33 (or PT if I have Medicare) and reprocess as preventive with no cost sharing."

The other 2022 fix: if you did a stool-based screening (FIT, FIT-DNA/Cologuard, or a CT colonography) and it came back positive, the follow-up colonoscopy is no longer treated as diagnostic. Under ACA FAQ Part 51, it is treated as the completion of the screening — because a stool-based test alone doesn't confirm or rule out a lesion; the colonoscopy is the completion step of the screening algorithm.

This one still trips up plans and billing systems in 2026 because the referral pattern (positive Cologuard → colonoscopy) can easily be coded as diagnostic if the ordering physician isn't careful. Two safeguards:

• The referral wording matters. The referral should say "colorectal cancer screening completion following positive [Cologuard/FIT] result" — not "abnormal stool test, evaluate." The former reads as screening; the latter reads as diagnostic workup.
• Diagnosis code. Z12.11 or Z12.12 (Encounter for screening) should be primary. R19.5 (abnormal stool) or R19.7 (diarrhea) as primary is what triggers diagnostic billing.

Medicare adopted the same rule effective January 1, 2023, so for Medicare beneficiaries in 2026 a follow-up colonoscopy after a positive screening stool test is Part B preventive at $0 cost sharing when the appropriate modifier and coding are used.

Even when everything goes right, you will see paperwork. What you should see is an Explanation of Benefits (EOB) that shows the plan paid the negotiated rate in full and lists your responsibility as $0.00. What a fully covered screening looks like in the EOB, line by line:

• Facility charge: billed $3,200, allowed $1,850, plan paid $1,850, patient responsibility $0.
• Endoscopist charge: billed $1,100, allowed $525, plan paid $525, patient responsibility $0.
• Anesthesia charge: billed $850, allowed $340, plan paid $340, patient responsibility $0.
• Pathology (if biopsies): billed $290, allowed $115, plan paid $115, patient responsibility $0.

Total to the plan: roughly $2,000–$3,000 in the typical commercial-plan case, depending on region and facility type (an ambulatory surgery center runs 30–50% less than a hospital outpatient department for the same procedure). Total to you: zero, if everything is coded and delivered as preventive and in-network.

Self-pay pricing for reference: a colonoscopy without insurance in 2026 typically runs $2,100–$3,500 at an ambulatory surgery center and $2,800–$5,500 at a hospital outpatient department, all-in with anesthesia and pathology. Regional cash prices vary widely — the Procedure Cost Finder can give you a local benchmark for what the facility should be billing your plan.

A phone call to the practice's billing office resolves roughly 60% of screening-colonoscopy surprise bills — they resubmit with the correct code and the plan reprocesses. When that doesn't work, escalate in this order:

1. Written internal appeal to the plan

Send a letter to your plan citing ACA Section 2713 and ACA FAQ Part 51 (January 10, 2022). Attach the EOB, the denial or bill, and any benefits-verification letter you got before the procedure. Request that the claim be reprocessed as preventive with $0 cost sharing.

2. External review

After the internal appeal is exhausted, ACA-compliant plans must offer an independent external review at no cost to you. For a preventive-coverage question, the outcome is nearly always in the patient's favor because the underlying federal guidance is unambiguous. External review decisions are legally binding on the plan.

3. Regulator — DOL EBSA or state DOI

If the plan drags its feet or refuses to reprocess, file with the Department of Labor Employee Benefits Security Administration (askebsa.dol.gov or 1-866-444-3272) for employer-sponsored ERISA plans, or your state Department of Insurance for fully insured plans. Both regulators actively enforce ACA preventive-coverage rules and will require the plan to respond in writing, usually within 30–45 days.

4. No Surprises Act — for out-of-network facility staff

If the endoscopist was in-network but the anesthesia group or pathologist was not, the No Surprises Act (in effect since January 1, 2022) prohibits balance billing you at more than the in-network cost-sharing rate. Combined with the preventive-coverage rule that sets that in-network cost sharing at $0, the practical result is the same: you owe nothing. Include the NSA in your appeal letter as a belt-and-suspenders argument.

Traditional Medicare

Screening colonoscopy is covered under Medicare Part B with no coinsurance and no Part B deductible for average-risk beneficiaries every 10 years (G0121) and for high-risk beneficiaries every 24 months (G0105). Polyp removal during a screening does not trigger a bill when the provider uses modifier PT. Follow-up colonoscopy after a positive stool test is fully covered as of January 1, 2023. Verify your provider knows to bill G0121/G0105 rather than 45378 for the base screening — a Medicare-specific coding error.

Medicare Advantage

Medicare Advantage plans must match Original Medicare's preventive coverage — $0 for screening. If a Medicare Advantage plan bills you for a screening colonoscopy, escalate to 1-800-MEDICARE and file a complaint through the plan's grievance process; the coverage rule is federal and non-negotiable.

HDHPs and HSA-eligible plans

Screening colonoscopy is one of the enumerated preventive services that HDHPs can and must cover before the deductible without threatening HSA eligibility (IRS Notice 2004-23, updated repeatedly). If your HDHP applied the deductible, it's a coding error, not a plan-design constraint. Use the HSA vs FSA Calculator to model what a correctly billed screening does (and doesn't) do to your annual HSA balance.

Marketplace Bronze plans

Every ACA marketplace plan — Bronze, Silver, Gold, Platinum — must cover USPSTF A/B preventive services at $0 in-network. A Bronze plan with a $9,000 deductible still covers screening colonoscopy fully. If a Bronze plan tries to apply the deductible to a correctly coded screening, that's an ACA compliance violation, not a benefit design. Use the Plan Cost Calculator to see how much a correctly covered screening actually saves you against a full-price cash bill.

Two weeks before your colonoscopy, run this five-item checklist:

1. Confirm the referral is screening, not diagnostic. Ask your PCP to write "colorectal cancer screening" as the referral reason with diagnosis Z12.11. If you have a symptom on the referral, ask whether it needs to be there — sometimes it does clinically, but if not, remove it.
2. Get in-network confirmation for all four billers. Endoscopist, facility, anesthesia group, and pathology lab. Ask the scheduling office to name the anesthesia and pathology entities so you can verify them separately with your plan.
3. Confirm the coding plan. CPT 45378 + modifier 33 (commercial) or G0121/G0105 (Medicare). Anesthesia CPT 00812. Modifier 33 or PT on any polypectomy CPT that gets billed.
4. Verify the bowel-prep coverage. If prescribed a brand prep, ask the plan whether it's covered as part of the preventive screening (yes, under FAQ Part 51 for generic or brand-with-no-generic-equivalent). If pushed toward MiraLAX/OTC, ask for a written preventive-coverage exception.
5. Get a benefits-verification letter. Ask the practice for an emailed pre-procedure benefits letter listing the codes and confirming $0 patient responsibility. Save it. This is the artifact that resolves a later billing dispute in one email.

A screening colonoscopy in 2026 should cost you nothing. The federal rules that make it free are settled and enforceable: ACA Section 2713 for cost-sharing elimination, ACA FAQ Part 51 (January 2022) for polyp-removal and post-positive-Cologuard follow-up coverage, and matching Medicare policy effective 2023. What still goes wrong is the billing implementation — coders and claims systems miscount modifiers, anesthesia groups auto-select the diagnostic CPT, referrals get written with the wrong diagnosis code, and out-of-network sub-providers slip through in-network facilities.

Prevent the bill before the procedure by asking scheduling about codes, in-network status for all four billers, and the anesthesia CPT they intend to use — and by getting a benefits-verification letter in writing. Reverse a bill after the procedure with a phone call to the billing office asking for a modifier-33 or modifier-PT correction, and, if that fails, a written appeal citing ACA Section 2713 and FAQ Part 51. Add DOL EBSA (for ERISA plans) or your state DOI (for fully insured plans) to the CC line if the plan resists. The federal rules are on your side; the coding cleanup is the only work you have to do.